Webcasts
The UW CFAR Administrative, International and Clinical Cores are pleased to present webcasts of the AIDS Clinical Conference Lecture Series and the CFAR Seminar Series. Webcasts are supported by CFAR; Fred Hutchinson Cancer Research Center; and Treatment, Research, and Expert Education (TREE) through a grant from the President's Emergency Plan for AIDS Relief (PEPFAR). Through this project, we aim to make these lectures accessible to the local and international HIV research and care community.
Featured Talks:
Management of HIV and
Tuberculosis Co-Infection: From Clinical Practice to a Global
Perspective
Richard Chaisson, MD
Director, Center for Tuberculosis
Research
Johns Hopkins University
January 19, 2010
Global HIV Prevention
Research: Where are the gaps and how can we fill them?
Sten Vermund, MD,
PhD
Director, Institute for Global Health
Vanderbilt University School of
Medicine
January 7, 2010
Old and New Challenges
in HIV Prevention
Peter Piot, MD, PhD, FRCP
Chair, Institute for
Global Health, Imperial College, London
December 9, 2009
Exploring Chlamydial
Phenotypes Using Rapid Genome Sequencing
Dan Rockey, PhD
Associate
Professor of Biomedical Sciences, Oregon State University
December 9,
2009
Male Circumcision:
Beyond HIV Prevention for Heterosexual Men
Robert Bailey, PhD,
MPH
Epidemiology and Biostatistics, University of Illinois at
Chicago
December 3, 2009
Archived Talks:
Hot Topics in
Antiretroviral Therapy, Yet Another 'When to Start' Lecture!
Joel
Gallant, MD, MPH
Professor of Medicine, Johns Hopkins University School of
Medicine
November
18, 2009
HSV-2 and
HIV: The Epidemiology, The Clinical Trials, and the Lessons
Learned
Connie Celum, MD, MPH
Professor of Medicine and Global Health,
University of Washington
Director, International Clinical Research
Center
November 5, 2009
Contemporary Issues in the Management of the Treatment Experienced
Patient
Eric S. Daar, MD
Chief, Division of HIV
Medicine
Harbor-UCLA HIV Medicine Research Center
Professor of Medicine,
David Geffen School of Medicine at UCLA
October 20, 2009
HIV DNA
priming alters the character of the vaccine-induced T cell response to
recombinant adenovirus boosting even when the response to DNA is
undetectable
Steve De Rosa, MD
University of Washington/Fred
Hutchinson Cancer Research Center
October 1, 2009
Advances in
the Diagnosis, Management and Epidemiology of Cancers Associated with HIV
Infection
Corey Casper, MD MPH
Associate Professor of Medicine,
University of Washington
Assistant Member, Fred Hutchinson Cancer Research
Center
Medical Director of Infection Control, Seattle Cancer Care
Alliance
September 29, 2009
Scaling up
the Care and Treatment of HIV Infected Children Globally: Lessons From the Field
in Romania and Sub-Saharan Africa
Mark W. Kline, M.D.
J.S. Abercrombie
Professor and Chairman
Department of Pediatrics, Baylor College of
Medicine
Physician-in-Chief, Texas Children's Hospital
August 18, 2009
Safer
Conception and Contraception in the Setting of HIV
Jane Hitti, MD,
MPH
University of Washington
Amy Criniti, MD
Seattle Reproductive
Medicine
June 9, 2009
HIV variation
and approaches to develop a global HIV vaccine
Bette Korber, PhD
Los
Alamos National Laboratory
June 4, 2009
Viral Loads
and the Global Epidemic. Implications for Clinical Care:
Analyses of
Variation in HIV Viral Load Consistent with Role for Co-infection in Regional
Differences in HIV Epidemic Trajectory
Ruanne Barnabas, MBChB,
DPhil
Fred Hutchinson Cancer Reseach Center
May 19, 2009
Neutralizing
antibody in HIV and SIV infection
Cynthia A. Derdeyn, PhD
Department
of Pathology and Laboratory Medicine
Emory Vaccine Center, Emory
University
May 7, 2009
When to Start
Antiretroviral Therapy? Earlier Initiation Improves Survival
Mari M.
Kitahata, MD, MPH
Associate Professor of Medicine
Director of Clinical
Epidemiology & Health Services Research
Center for AIDS Research,
University of Washington
April 21st, 2009
PLEASE NOTE:
Due to technical difficulties, there is no audio for the initial two minutes of
the recording. It resumes and continues with a few brief interruptions to
completion.
A
Multidisciplinary Approach to the Prevention, Pathophysiology and Treatment of
HIV-Associated Malignancies: The Continually-Evolving Relationship Between
Cancer and HIV
Corey Casper, MD, MPH
Fred Hutchinson Cancer Research
Center
April 2, 2009
Update from
the Conference of Retroviruses and Opportunistic Infections (CROI)
Joanne
Stekler, MD
Chad Achenbach, MD
Ann Collier, MD
David Spach,
MD
University of Washington
March 17, 2009
HIV AIDS
Research: Lessons from the Early Years and the Needs Now
Robert Gallo,
MD
Institute of Human Virology, School of Medicine, University of
Maryland
March 5, 2009
Pre-exposure
Prophylaxis (PrEP) for HIV Prevention
Jared Baeten, MD, PhD
University
of Washington
January 13, 2009
Racial
Disparities in HIV among African Americans
David Malebranche, MD,
MPH
Emory University, Atlanta, GA
October 14, 2008
HIV and
Hepatitis Coinfection
John Scott, MD
University of
Washington
September 16, 2008
Global AIDS
Prevention: the Good, the Bad and the Ugly
Tom Quinn, MD
Professor and
Director, Johns Hopkins Center for Global Health
Johns Hopkins University,
Bloomberg School of Public Health
July 31, 2008
Solid Organ
Transplantation in HIV+ Recipients: The Unexpected Findings
Peter Stock,
MD, PhD.
UC San Francisco
July 15, 2008
Management
of the Treatment Experienced Patient
Eric Daar, MD
HIV Medicine
Research Center, UCLA
May 20, 2008
Update from
2008 Conference on Retroviruses and Opportunistic Infections
(CROI)
Robert Harrington MD
Ann Collier MD
Jeff Schouten
MD
Joanne Stekler MD
University of Washington
April 15, 2008
HSV-2 and
HIV Synergy and Interventions: Update from HPTN 039 and Partners in Prevention
Trials
Connie L. Celum, MD, MPH
Professor of Medicine and Global
Health, University of Washington
March 18, 2008
International Perspectives of Adherence and Resistance to HIV
Therapy
David Bangsberg MD, MPH
Associate Professor of Medicine,
University of California, San Francisco
February 19, 2008
